Prof. Dr. med. Benjamin Meder

Ärztlicher / Beruflicher Werdegang
Full Professor (W3) for Precision Digital Health, University Heidelberg
Head of Section for Cardiomyopathies
Deputy Medical Director
Managing Senior Physician
Associate Professor (Priv.-Doz.) of Internal Medicine
Senior Physician
Medical Specialist for Internal Medicine and Cardiology
Free journalist (medicine and science)
Wissenschaftlicher Werdegang
Head of Genomic Research at the Department of Internal Medicine III, University Hospital of Heidelberg
Research group leader, Laboratory of Molecular Genetics, Department of Internal Medicine III, University Hospital of Heidelberg
Postdoctoral research fellow in the group for Functional Genomics (Prof. W. Rottbauer), Department of Internal Medicine III, University of Heidelberg
Scientific Assistant, Laboratory of Engineering & Bioinformatics, Perfusion Technologies GmbH
Research doctorate, Department of Cardiology, University Hospital of Freiburg
Medical School, Albert-Ludwigs-University of Freiburg
Auszeichnungen
Else Kröner-Excellence Fellowship
1. Price German Society of Cardiology “Cardio Science Slam”
Winterstein Science Award of the German Heart Foundation
European Society of Cardiology “primus inter pares”
Research fellowship (Young Investigator Award) of the Medical Faculty, University of Heidelberg
Winterstein Science Award of the German Heart Foundation
Best Poster Award, 7th Dutch-German Meeting of the Molecular Cardiology Groups
Scholarship of Bayer Foundations, Leverkusen, Germany
E-fellows scholarship, Munich, Germany
Mitgliedschaften
Invited as Fellow of the Walter-Siegenthaler Gesellschaft
Fellow of the Royal Society of Medicine
Member ESC Council on Cardiovascular Genomics
Fellow of the Biophysical Society
ESC Working Group on Myocardial and Pericardial Disease
Cardiolinc Consortium Member
Fellow of the European Society of Cardiology (FESC;)
Translational Research Committee Member of the Heart Failure Association
Genomics Proteomics Bioinformatics
Editorial Board Member Frontiers Cardiovascular Medicine.
DGK working group 12 “Cardiomyopathies” – Nucleus member, Speaker 2021 - 2023
Deutsche Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V.
DGK working group 8 „Genetik und Molekularbiologie kardiovaskulärer Erkrankungen“
Gut-Glut Heidelberg e.V.
Deutscher Fachjournalisten-Verband (German Association of Specialized Journalists)
Ämter und Funktionen
Speaker eCardiology, German Cardiac Society
Program Coordinator Cardiology Summit of the German Society of Cardiology
Co-Coordinator and member of the Board of Directors Informatics for Life Consortium
Coordinator of the Innovation Alliance “Subgenome Fractionation for High-throughput Sequencing”
Coordinator Cardiomyopathy Group DZHK Registries
Steering committee of the Network for Congenital Heart Diseases
Coordinator Cardiomyopathy Research Board & Institute for Cardiomyopathies Heidelberg (ICH.)
Clinical education
DGK qualification Interventional Cardiology
Clinical specialty
Kardiomyopathien:
- Dilatative Cardiomyopathie (DCM)
- Linksventrikuläre Noncompaction-Cardiomyopathie (LVNC)
- Arrhytmogene Rechtsventrikuläre Cardiomyopathie (ARVC)
- Tako Tsubo Syndrom
Klinische Schwerpunkte
Interventionelle Kardiologie
Kardiomyopathien
Experimentelle Schwerpunkte
Genetik und Epigenetik von Kardiomyopathien
Translationale Biotechnologie
Omics-basierte Biomarker
Funding
Cardiac Splicing as a Therapeutic Target (CASTT) (Leducq Foundation)
Sonderforschungsbereich CRC1550 (Deutsche Forschungsgemeinschaft – DFG)
Kausale Modellierung und adaptives experimentelles Design für Einzelzell-Perturbations-Experimente ((Deutsche Forschungsgemeinschaft – DFG)
AI Health Innovation Cluster Heidelberg (MWK Baden-Württemberg)
Translational Registry for Cardiomyopathies TORCH-Plus (DZHK BMBF)
CARDIATEAM within innovative medicines initiative (IMI, EU and EFPIA)
ActiveDCM interventional Trial (Deutsche Herzstiftung und Apple Inc.)
Regulation of myosin-light chains (DFG)
Informatics for Life (Klaus-Tschira Stiftung)
Hereditary sick sinus syndrome – phenotypic spectrum, genetic basis, cellular dysfunction and implications for therapy (Deutsche Forschungsgemeinschaft – DFG)
Else Kröner-Exzellenz-Stipendium
HIGHmed (BMBF)
Leben mit Kardiomyopathie (Deutsche Herzstiftung)
ERA-CVD Detectin-HF (EU, BMBF).
Promise (BMBF)
eMed Systems Biology CaRNAtion (BMBF)
Klaus Tschira Foundation
BestAgeing (EU FP7)
“Translational Biotechnology” (Siemens AG)
Innovationsfond FRONTIER “Development of miRNA-based biomarkers” (University of Heidelberg)
INSIGHT DCM (BMBF/EU); INHERITANCE – Genetics of Dilated Cardiomyopathy (EU FP7);
INSIGHT DCM (BMBF/EU); INHERITANCE – Genetics of Dilated Cardiomyopathy (EU FP7);
NGFN Plus project “DNA and Mutation-Screening Platform” (BMBF)
German Center for Cardiovascular Research – DZHK (BMBF)
NGFN Transfer project “Targeted Next-Generation Sequencing” (BMBF)
Start-up of an Excellence Cluster: “Heart and Cancer” (MWK)
Translational Registry for Cardiomyopathies TORCH (DZHK BMBF)
Patents Applications
US 61/326,043 Complex miRNA sets as novel biomarkers for an acute coronary syndrome;
EP 10 004 190.4 Complex miRNA sets as novel biomarkers for an acute coronary syndrome;
US 13/642,321 Complex miRNA sets as novel biomarkers for an acute coronary syndrome;
EP 11715666.1 Complex miRNA sets as novel biomarkers for an acute coronary syndrome;
PCT/EP2011/001999 Complex miRNA sets as novel biomarkers for an acute coronary syndrome;
EP 101 851 36.8 Complex miRNS sets as novel biomarkers for an acute coronary syndrome;
EP 11169192.9 MicroRNA signatures als Biomarker für die dilatative Kardiomypathie (DCM) und Herzinsuffizienz; PCT/EP2012/060927 Complex set of miRNAs as noninvasive biomarkers for dilated cardiomyopathy;
13 709 132.8 Epigenetic signatures as markers for cardiomyopathies and myocardial insufficiensies;
PCT/EP2013/055267 Epigenetic signatures as markers for cardiomyopathies and myocardial insufficiensies;
EP12163180.8 Complex sets of miRNAs as non-invasive biomarkers for early diagnosis of acute myocardial infarction;
PCT/EP2013/057118 Complex sets of miRNAs as non-invasive biomarkers for early diagnosis of acute myocardial infarction;
EP 13168684.2 MICRORNA as non-invasive biomarkers for heart failure
Personal- und Officemanagement Kardiologie, Angiologie, Pneumologie
Öffnungszeiten
| Mo – Do | 07:00 – 15:30 |
| Fr | 07:00 – 13:30 |


